ASCO GU 2021: Comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for advanced papillary kidney cancer
A gene called MET codes for a protein called MET [...]
Update on papillary kidney cancer
The following is an interview with Dr Ramaprasad Srinivasan, Head of the [...]
Crizotinib shows promise in type 1 papillary kidney cancer
Papillary kidney cancer is a rare subtype of renal cell [...]
